Parcourir par auteur "Daskalopoulou, S. S."
Voici les éléments 1-3 de 3
-
Effect of Ranolazine in Preventing Postoperative Atrial Fibrillation in Patients Undergoing Coronary Revascularization Surgery
Tagarakis, G. I.; Aidonidis, I.; Daskalopoulou, S. S.; Simopoulos, V.; Liouras, V.; Daskalopoulos, M. E.; Parisis, C.; Papageorgiou, K.; Skoularingis, I.; Triposkiadis, F.; Molyvdas, P. A.; Tsilimingas, N. B. (2013)Background/Objective: Ranolazine is a new anti-ischemic agent approved for chronic angina with additional electrophysiologic properties. The purpose of the present trial was to investigate its effect in preventing postoperative ... -
Ranolazine enhances nicardipine-induced relaxation of alpha1-adrenoceptor-mediated contraction on isolated rabbit aorta
Malavaki, C.; Hatziefthimiou, A.; Daskalopoulou, S. S.; Stefanidis, I.; Karatzaferi, C.; Aidonidis, I. (2015)Ranolazine (RAN) and nicardipine (NIC) have been studied for their vasorelaxing effects but the combination of these agents against adrenergic vasoconstriction has not been tested. The present study aimed at investigating ... -
Ranolazine Enhances the Antiarrhythmic Activity of Amiodarone by Accelerating Conversion of New-Onset Atrial Fibrillation After Cardiac Surgery
Simopoulos, V.; Tagarakis, G. I.; Daskalopoulou, S. S.; Daskalopoulos, M. E.; Lenos, A.; Chryssagis, K.; Skoularingis, I.; Molyvdas, P. A.; Tsilimingas, N. B.; Aidonidis, I. (2014)Ranolazine is a relatively novel antiischemic/antianginal compound with antiarrhythmic properties. We investigated its ability to shorten the time to conversion of postoperative atrial fibrillation (POAF) when added to ...